Open Chromatin State of Dpp4 With Glucocorticoid Treatment-Setting up Shop for Metasteroid Diabetes?

Endocrinology. 2022 Jan 1;163(1):bqab220. doi: 10.1210/endocr/bqab220.

Authors

Nadya M Morrow^{1

2}, Erin E Mulvihill^{1

2

3

4}

Affiliations

¹ The University of Ottawa, Faculty of Medicine, Department of Biochemistry, Microbiology and Immunology, Ottawa, Ontario, K1H 8M5, Canada.
² The University of Ottawa Heart Institute, Ottawa, Ontario K1Y 4W7, Canada.
³ Centre for Infection, Immunity and Inflammation, Ottawa, Ontario, Canada.
⁴ Montreal Diabetes Research Group, Montreal, Quebec H2X 0A9, Canada.

No abstract available

Keywords: dipeptidyl peptidase 4; epigenetics; glucagon-like peptide 1; glucocorticoids; histone acetylation; metasteroid diabetes.

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Chromatin
Diabetes Mellitus*
Dipeptidyl Peptidase 4
Glucocorticoids*

Substances

Chromatin
Glucocorticoids
Dipeptidyl Peptidase 4

Grants and funding

156136/CIHR/Canada